Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation
Eileen P. Scully(Johns Hopkins University), Steven G. Deeks(University of California, San Francisco), Jeffrey M. Milush(University of California, San Francisco), Robert J. Gorelick(Frederick National Laboratory for Cancer Research), Monica Gandhi(University of California, San Francisco), Rebecca Hoh(University of California, San Francisco), Marcus Altfeld(Harvard University), Jeffrey D. Lifson(Science Applications International Corporation (United States)), Arlvin Ellefson(Johns Hopkins University), Jonathan Karn(Case Western Reserve University), Valerie Girling, Peter Bacchetti(University of California, San Francisco), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Sharon R. Lewin(Peter Doherty Institute), Chris A. R. Baker(University of California, San Francisco), Marcelle I. Cedars(University of California, San Francisco), Nicolas Chomont(Vaccine & Gene Therapy Institute of Florida), Rowena Johnston(American Foundation for AIDS Research), Curtis Dobrowolski(Georgia Institute of Technology), Amélie Pagliuzza(Centre Hospitalier de l’Université de Montréal), Ajantha Solomon(The Royal Melbourne Hospital), Ainsley Lockhart(Ragon Institute of MGH, MIT and Harvard)
Cited by 100
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
|Nature Medicine|2009|1.7k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k